Profile
H.
Michael Hogan currently works at Otonomy, Inc., as Director from 2023 and Metacrine, Inc., as Director from 2023.
Mr. Hogan also formerly worked at Nabriva Therapeutics Plc, as Chief Executive Officer and Armanino LLP (United States), as Partner.
Mr. Hogan received his undergraduate degree from Colgate University.
H. Hogan active positions
| Companies | Position | Start |
|---|---|---|
| METACRINE, INC. | Director/Board Member | 23/03/2023 |
| OTONOMY | Director/Board Member | 15/02/2023 |
Former positions of H. Hogan
| Companies | Position | End |
|---|---|---|
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Corporate Officer/Principal | - |
| NABRIVA THERAPEUTICS PLC | Chief Executive Officer | - |
Training of H. Hogan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Commercial Services |
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Metacrine, Inc.
Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
- Stock Market
- Insiders
- H. Hogan
















